authenticity, provenance and assurance in the provision of goods and services This report should be cited as: Annual Report of the Government Chief Scientific Adviser 2015 Forensic Science and Beyond: Authenticity, Provenance and Assurance The Government Office for Science, London
Forensic Science and Beyond: Authenticity, Provenance and Assurance Evidence and Case Studies This volume comprises chapters which form the evidence for the Government Chief Scientific Adviser’s Annual Report 2015, together with illustrative case studies It should be cited as:
Forensic science and beyond: authenticity, provenance and assurance Sir Mark Walport FRS Chief Scientific Adviser to HM Government 2016 Government Chemist Conference
Encouraging innovation In: Forensic science and beyond: authenticity, provenance and assurance - evidence and case studies Government Office for Science, 174-
Annual Report of the Government Chief Scientiic Adviser 2015: Forensic Science and Beyond: Authenticity, Provenance and Assurance Evidence and Case Studies The Government Ofice for Science would like to thank the authors who contributed evidence chapters, case studies and their time towards this report and gave it freely
this important link between forensic/measurement science and compliance across multiple markets was further outlined in Sir Mark Walport’s Government Chief Scientist Annual Report entitled “Forensic Science and Beyond: Authenticity, Provenance and Assurance” that was published late in 2015
This article responds to the publication of Forensic Science and Beyond: Authenticity, Provenance and Assurance (hereinafter Walport) by addressing the three policy objectives falling within the hief Scientific Adviser [s remit, namely: (a) identifying how significant emerging technology might be
Pharmaceutical counterfeiting is a global threat that can kill patients, contributes to the rise of drug resistance, and increases citizens' mistrust of health systems